Patient’s baseline and surgical characteristics | |
Diagnosis; n (%) | |
Confirmed | 9 (45) |
Suspicious | 11(55) |
Age [Mean±SD (Range)]; year | 50±9 (35-68) |
BMI [Mean±SD (Range)]; kg/m2 | 24.5±4.8 |
Previous surgery; n (%) | |
None | 11(55) |
Unilateral Anexectomy | 4 (20) |
Bilateral Anexectomy | 1 (5) |
Bilateral Anexectomy+Hysterectomy | 4 (20) |
Ca 125 [Mean±SD (Range)]; IU/mL | 155.6±241 (6.9–818) |
Ca 19.9 [Mean±SD (Range)]; IU/mL | 114.7±204 (2-875) |
ASA score; n (%) | |
I-II | 17.0 (85) |
III | 3.0 (15) |
Approach; n (%) | |
Laparoscopy | 9 (45) |
Laparotomy | 11 (55) |
Type of surgery; n (%) | |
Frozen section+Surgical staging | 11 (55) |
Differed surgical staging | 9 (45) |
Main Tumor Size [Mean±SD (Range)]; mm | 108.7±72.7 (2–250) |
Ascites [Mean±SD (Range)]; ml | 77.5±103 (0–400) |
Tumor location; n (%) | |
Left | 10 (50) |
Right | 9 (45) |
Bilateral | 1 (5) |
Estimated blood loss [Mean±SD (Range)]; ml | 257.5±114 (100-500) |
Red blood transfusion; n (%) | 0 (0) |
Surgical time [Mean±SD (Range)]; min | 275±29 (210-320) |
Intraoperative complications; n (%) | |
No | 18 (90) |
Vascular injury | 2 (5) |
ASA; BMI, body mass index; FIGO, The International Federation of Gynecology and Obstetrics.